Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; Issues related to pandemic preparedness, including awareness and support for influenza A preparedness.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2010 · second_quarter · Q2
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Source: Senate LDA
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; Issues related to pandemic preparedness, including awareness and support for influenza A preparedness.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293 (and Senate version, not yet introduced): FY 2010 Labor/HHS/Education Appropriations appropriations, provisions related to viral hepatitis funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations appropriations, provisions related to viral hepatitis funding.
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations appropriations, provisions related to viral hepatitis funding.
Hepatitis C Epidemic Control and Prevention Act of 2007
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); Draft legislation related to safety of imported drug products. HR 2552: Hepatitis C Epidemic Control and Prevention Act of 2007 - All provisions (not yet reintroduced in current Congress)
Hepatitis C Epidemic Control and Prevention Act of 2007
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 all provisions Draft legislation related to safety of imported drug products.
Hepatitis C Epidemic Control and Prevention Act of 2007
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising the awareness of Hepatitis C (no specific bill); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bill); HR 2552, all provisions.
Hepatitis C Epidemic Control and Prevention Act of 2007
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 - Hepatitis C Epidemic Control Prevention Act of 2007; all provisions; Increased appropriations for CDC/FDA.
Hepatitis C Epidemic Control and Prevention Act of 2007
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: VERTEX PHARMACEUTICALS INCORPORATED
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 all provisions Draft legislation related to saftey of imported drug products.
2010 · first_quarter · Q1
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; Issues related to pandemic preparedness, including awareness and support for influenza A preparedness.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2009 · fourth_quarter · Q4
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations appropriations, provisions related to viral hepatitis funding.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2009 · third_quarter · Q3
Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293 (and Senate version, not yet introduced): FY 2010 Labor/HHS/Education Appropriations appropriations, provisions related to viral hepatitis funding.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2009 · second_quarter · Q2
Issues related to raising awareness of Hepatitis C (no specific bills); FY 2010 appropriations.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2009 · first_quarter · Q1
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); Draft legislation related to safety of imported drug products. HR 2552: Hepatitis C Epidemic Control and Prevention Act of 2007 - All provisions (not yet reintroduced in current Congress)
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2008 · fourth_quarter · Q4
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 - Hepatitis C Epidemic Control Prevention Act of 2007; all provisions; Increased appropriations for CDC/FDA.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2008 · third_quarter · Q3
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 all provisions Draft legislation related to safety of imported drug products.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2008 · second_quarter · Q2
Issues related to raising awareness of Hepatitis C (no specific bills); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bills); HR 2552 all provisions Draft legislation related to saftey of imported drug products.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2008 · first_quarter · Q1
Issues related to raising the awareness of Hepatitis C (no specific bill); Issues related to implementation of FDAAA, BIO priorities (Chairmanship) (no specific bill); HR 2552, all provisions.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VERTEX PHARMACEUTICALS INCORPORATED via VERTEX PHARMACEUTICALS INCORPORATED
2008 · first_quarter · RR
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.